Cargando…

Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients

AIMS: Routine, intermittent inotropic therapy (IIT) is still applied in advanced heart failure (HF) patients either as a bridge to definitive treatment or as a mean to improve quality of life (QOL), despite limited evidence to support its' use. Given recent reports of improved QOL and reduced H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milwidsky, Assi, Frydman, Shir, Laufer‐Perl, Michal, Sadeh, Ben, Sapir, Orly, Granot, Yoav, Hochstadt, Aviram, Korotetski, Liuba, Ketchker, Liora, Topilsky, Yan, Banai, Shmuel, Havakuk, Ofer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934941/ https://www.ncbi.nlm.nih.gov/pubmed/35083882 http://dx.doi.org/10.1002/ehf2.13807

Ejemplares similares

Repetitive milrinone therapy in ambulatory advanced heart failure patients
por: Laufer‐Perl, Michal, et al.
Publicado: (2022)

Successful conservative management of left ventricular assist device candidates
por: Havakuk, Ofer, et al.
Publicado: (2022)

Primary Cardiac Lymphoma Patients Presenting With Heart Failure
por: Ghantous, Eihab, et al.
Publicado: (2023)

Cardiorespiratory Abnormalities in Patients Recovering from Coronavirus Disease 2019
por: Szekely, Yishay, et al.
Publicado: (2021)

The added predictive role of echocardiography in patients with mild or moderate Coronavirus Disease 2019
por: Lupu, Lior, et al.
Publicado: (2023)

Pericardial Involvement in Patients Hospitalized With COVID‐19: Prevalence, Associates, and Clinical Implications
por: Ghantous, Eihab, et al.
Publicado: (2022)

THE LONG-TERM PROGNOSTIC SIGNIFICANCE OF ECHOCARDIOGRAPHY FINDINGS IN COVID-19 PATIENTS
por: Lupu, Lior, et al.
Publicado: (2022)

The Predictive Role of Combined Cardiac and Lung Ultrasound in Coronavirus Disease 2019
por: Szekely, Yishay, et al.
Publicado: (2021)

A validated score to predict one-year and long-term mortality in patients with significant tricuspid regurgitation
por: Hochstadt, Aviram, et al.
Publicado: (2022)

The Mechanism of Effort Intolerance in Patients with Peripheral Arterial Disease: A Combined Stress Echocardiography and Cardiopulmonary Exercise Test
por: Ghantous, Eihab, et al.
Publicado: (2023)

Clustering of clinical and echocardiographic phenotypes of covid-19 patients
por: Shpigelman, Eran, et al.
Publicado: (2023)

Levosimendan, milrinone, and dobutamine in experimental acute pulmonary embolism
por: Lyhne, Mads D., et al.
Publicado: (2021)

COVID-19, a tale of two peaks: patients’ characteristics, treatments, and clinical outcomes
por: Banai, Ariel, et al.
Publicado: (2021)

Association between C-Reactive Protein Velocity and Left Ventricular Function in Patients with ST-Elevated Myocardial Infarction
por: Banai, Ariel, et al.
Publicado: (2022)

Inotropic support in cardiogenic shock: who leads the battle, milrinone or dobutamine?
por: Lozada Martinez, Ivan David, et al.
Publicado: (2022)

Coronary Sinus Narrowing Improves Right Ventricular Function
por: Mann, Tomer D., et al.
Publicado: (2022)

PERICARDIAL INVOLVEMENT IN HOSPITALIZED PATIENTS WITH COVID-19- PREVALENCE, ASSOCIATES AND CLINICAL IMPLICATIONS
por: Ghantous, Eihab, et al.
Publicado: (2022)

QT INTERVAL PROLONGATION IS A NOVEL PREDICTOR OF 1-YEAR MORTALITY IN PATIENTS WITH COVID-19 INFECTION
por: Banai, Ariel, et al.
Publicado: (2022)

QT Interval Prolongation Is a Novel Predictor of 1-Year Mortality in Patients With COVID-19 Infection
por: Banai, Ariel, et al.
Publicado: (2022)

The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum
por: Levijoki, Jouko, et al.
Publicado: (2022)

Hyperglycemia raises the threshold of levosimendan- but not milrinone-induced postconditioning in rat hearts
por: Matsumoto, Shuhei, et al.
Publicado: (2012)

Risk stratification according to diastolic function indices in heart failure patients with mildly reduced or reduced ejection fraction
por: Granot, Yoav, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor-Induced Myocarditis vs. COVID-19 Vaccine-Induced Myocarditis—Same or Different?
por: Zornitzki, Lior, et al.
Publicado: (2022)

Correction to: Lung ultrasound predicts clinical course and outcomes in COVID-19 patients
por: Lichter, Yael, et al.
Publicado: (2020)

Lung ultrasound predicts clinical course and outcomes in COVID-19 patients
por: Lichter, Yael, et al.
Publicado: (2020)

Clinically Significant High-Grade AV Block as a Reversible Cause for Acute Kidney Injury in Hospitalized Patients—A Propensity Score Matched Cohort
por: Hochstadt, Aviram, et al.
Publicado: (2021)

Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamine
por: Manouchehri, Namdar, et al.
Publicado: (2012)

Sex differences in heart failure patients assessed by combined echocardiographic and cardiopulmonary exercise testing
por: Rozenbaum, Zach, et al.
Publicado: (2023)

Relation of Gender to the Occurrence of AKI in STEMI Patients
por: Frydman, Shir, et al.
Publicado: (2022)

Cardiologic Manifestations in Omicron‐Type Versus Wild‐Type COVID‐19: A Systematic Echocardiographic Study
por: Ghantous, Eihab, et al.
Publicado: (2023)

Proarrhythmic changes in human cardiomyocytes during hypothermia by milrinone and isoprenaline, but not levosimendan: an experimental in vitro study
por: Selli, Anders Lund, et al.
Publicado: (2023)

Relation of Mechanical Ventilation to Acute Kidney Injury in Myocardial Infarction Patients
por: Frydman, Shir, et al.
Publicado: (2023)

The prevalence of abnormal right ventricle speckle strain in the setting of acute myocarditis and preserved left ventricle function
por: Ben-Joya, Daniel, et al.
Publicado: (2023)

Inotropic Support in the Treatment of Septic Myocardial Dysfunction: Pathophysiological Implications Supporting the Use of Levosimendan
por: Morelli, A., et al.
Publicado: (2014)

Biomarker-Guided Assessment of Acute Kidney Injury Phenotypes E among ST-Segment Elevation Myocardial Infarction Patients
por: Banai, Ariel, et al.
Publicado: (2022)

Clinical Efficacy of Levosimendan vs Milrinone in Preventing Low Cardiac Output Syndrome Following Pediatric Cardiac Surgery
por: Jothinath, Kaushik, et al.
Publicado: (2021)

Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO‐D registry
por: Dobarro, David, et al.
Publicado: (2023)

Valvular Heart Disease following Anthracycline Therapy—Is It Time to Look beyond Ejection Fraction?
por: Zahler, David, et al.
Publicado: (2022)

BMI Modifies Increased Mortality Risk of Post-PCI STEMI Patients with AKI
por: Schvartz, Reut, et al.
Publicado: (2022)

Successful use of levosimendan as a primary inotrope in pediatric cardiac surgery: An observational study in 110 patients
por: Joshi, Reena Khantwal, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_srro0l9hpboiek3sc93f9ugh6o